Long term follow-up of multiple sclerosis by standardized, non-contrast-enhanced magnetic resonance imaging

[1]  P. Scheltens,et al.  Quantitative MRI changes in gadolinium‐DTPA enhancement after high‐dose intravenous methylprednisolone in multiple sclerosis , 1991, Neurology.

[2]  A. Kermode,et al.  Destructive lesions in demyelinating disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[3]  P. Parizel,et al.  Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of an extensive standardized imaging-protocol , 1990, Journal of the Neurological Sciences.

[4]  C. Pozzilli,et al.  Serial study of gadolinium‐DTPA MRI enhancement in multiple sclerosis , 1990, Neurology.

[5]  W. I. McDonald,et al.  Heterogeneity of blood‐brain barrier changes in multiple sclerosis , 1990, Neurology.

[6]  W. Mcdonald,et al.  Lessons from magnetic resonance imaging in multiple sclerosis , 1989, Trends in Neurosciences.

[7]  J. Martín,et al.  Improved sensitivity of MRI in multiple sclerosis by use of extensive standardized procedures. , 1989, Magnetic resonance imaging.

[8]  G. Johnson,et al.  Quantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[9]  H Lechner,et al.  Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis , 1988, Neurology.

[10]  J. Oger,et al.  Multiple sclerosis , 1988, Neurology.

[11]  B E Kendall,et al.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. , 1988, Brain : a journal of neurology.

[12]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[13]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.